C12N 2770/00034
Use of virus or viral component as vaccine
Official title: Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
C12N2770/00034 (Use of virus or viral component as vaccine) appears on 28 US grants and 46 published applications in this corpus.
Search patents in C12N- Granted patents
- 28
- Published applications
- 46
- Assignees
- 33
- Inventors
- 91
- Latest grant
- 8 Jul 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2010 | 0 | 1 |
| 2011 | 0 | 0 |
| 2012 | 0 | 1 |
| 2013 | 1 | 1 |
| 2014 | 1 | 5 |
| 2015 | 0 | 1 |
| 2016 | 1 | 2 |
| 2017 | 2 | 4 |
| 2018 | 4 | 3 |
| 2019 | 3 | 5 |
| 2020 | 4 | 4 |
| 2021 | 0 | 3 |
| 2022 | 5 | 1 |
| 2023 | 3 | 3 |
| 2024 | 3 | 10 |
| 2025 | 1 | 1 |
| 2026 | 0 | 1 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Cancer immunotherapy using virus particles8 Jul 2025US 12,350,326 B2Case Western Reserve University
- Virus and antigen conjugation24 Dec 2024US 12,173,328 B2Kbio Holdings Limited
- Melt processed viral nanoparticle constructs3 Dec 2024US 12,156,947 B2Case Western Reserve University
- Anticancer drug-containing plant virus particles30 Jan 2024US 11,883,505 B2Case Western Reserve University
- Cancer immunotherapy using virus particles22 Aug 2023US 11,730,803 B2Case Western Reserve University
- Oral vaccine20 Aug 2026US 2026/0240985 A1WestfäLische Wilhelms-UniversitäT MüNster
- Melt processed viral nanoparticle constructs19 Jun 2025US 2025/0195449 A1Case Western Reserve University
- Coronavirus vaccines19 Sep 2024US 2024/0307524 A1Luxembourg Institute of Health (LIH)
- Method for producing alfalfa mosaic virus-like particles using plant expression system and use thereof5 Sep 2024US 2024/0293335 A1Bioapplications Inc.
- Information provision method for examining active immunity by using production of neutralizing antibodies and interferon gamma5 Sep 2024US 2024/0295551 A1Boditech Med Inc.
Most cited
By later US patents
- Viral based transient-expression vector system that allows multiple applications7US 8,389,804 B2University of Florida Research Foundation, Inc. · 2013
- Methods and compositions for liposomal formulation of antigens and uses thereof2US 8,765,171 B2Molecular Express, Inc. · 2014
- Virus and antigen purification and conjugation1US 11,485,956 B2Kbio Holdings Limited · 2022
- Methods and compositions for liposomal formulation of antigens and uses thereof1US 9,931,419 B2Molecular Express, Inc. · 2018